GW26-e5379 Short-term Peri-procedural Common Doses (Double-Dose vs Usual-dose) of Atorvastatin for Prevention of Contrast-Induced Acute Kidney Injury and Long-term Outcomes in Patients with Different High CRP Levels undergoing Coronary Angiography or Percutaneous Coronary Intervention  by Liu, Yong et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C241ALI/ARDS by lung ultrasound in rats. The present study was designed
to investigate the degree of agreement of lung ultrasonography and
computed tomography (CT) results in diagnosing certain main char-
acteristics of ALI/ARDS in rats.
METHODS Thirty male Sprague-Dawley rats were randomized into
three groups, each group have ten rats. ALI/ARDS was induced in the
rats of the two experimental groups by intratracheal instillation of LPS
at different concentration (2 mg/ml LPS at 3 mg/kg, 4 mg/ml LPS at 6
mg/kg). The control group were instilled with the same volume of
isotonic saline solution. After two hours, lung ultrasound was per-
formed. Then, three rats in each group immediately underwent chest
micro-PET/CT scan. Cross table analyses and kappa statistics were
used to determine the levels of agreement between LUS and CT
assessments for the main characteristics of ALI/ARDS in rats.
RESULTS Most of the healthy rats presented A pattern; however, B
lines appeared when we instilled NS/LPS to the trachea, the LPS
groups showed more B lines than the NS group. One rat in the 4 mg/ml
LPS group presented a consolidation sign. The agreements between
the LUS and the CT in detecting the main characteristics of ALI/ARDS
in rat lungs were strong (k¼0.785). Additionally, a signiﬁcant corre-
lation was found between LUS and CT imaging in the detection of the
main characteristics of ALI/ARDS (r¼0.79. p<0.01).
CONCLUSIONS In an experimental rat model of ALI/ARDS, the data
showed that LUS can detect the main characteristics of ALI/ARDS with
high agreement with micro PET/CT scanning results, suggesting that
LUS is a good alternative for the diagnosis of ALI/ARDS in rats.GW26-e0775
Hypoalbuminemia complicated with pulmonary embolism 3 cases
Hua Zhang,1 Weihua Zhang,2 Yu Zhang,1 Jing Li1
1Seventh people’s hospital of zhengzhou city; 2The ﬁrst hospital of Jilin
University
OBJECTIVES Pulmonary embolism is a common fatal emergency, the
misdiagnosis rate and missed diagnosis is high, a variety of reasons
can cause or induce pulmonary embolism, however, the relationship
between hypoalbuminemia and pulmonary embolism is still a lack of
research, this article aims to explore hypoalbuminemia complicated
by pulmonary embolism related mechanism, so as to provide the basis
for clinical and basic research.
METHODS In recent years we caused by three different causes were
treated with hypoalbuminemia patients complicated with pulmonary
embolism were analyzed retrospectively and related literatures were
reviewed.
RESULTS Blood coagulation and ﬁbrinolysis imbalance, platelet ag-
gregation, increased blood viscosity, may be the result of pulmonary
embolism hypoalbuminemia mechanism.
CONCLUSIONS Emphasis on hypoalbuminemia merger risk factors of
pulmonary embolism, is very important for early diagnosis and
improve the prognosis.GW26-e3897
Investigation of detecting plasma lactate and NT-proBNP changes in
patients with pulmonary embolism subjected to thrombolytic treatment
Yiqiang Yuan, Jing Li, Qi Ding, Qiong H, Shuhong Wang
Department of Cardiology, Zhengzhou 7th People’s Hospital
OBJECTIVES To evaluate the efﬁcacy of thrombolytic therapy with
reteplase and investigate the clinical value of detecting plasma lactate
and N-terminal pro-brain natriuretic peptide (NT-proBNP) changes in
patients with acute pulmonary embolism (APE).
METHODS This was a retrospective study at the Cardiology depart-
ment of the hospital. All patients with a diagnosis of PE established
by lung scan or spiral computed tomography (CT) and conﬁrmed
by pulmonary angiography if necessary. From September 2011 to
September 2014, a total of 184 patients were diagnosed with PE. Of
these patients, 56 patients complied with the requirements for
thrombolytic therapy were included in this analysis. they were treated
with reteplase thrombolytic therapy. Plasma lactate, NT-proBNP and
cardiac troponin T(cTnT) levels were monitored before and up to ６h
after thrombolytic therapy. Echocardiography evaluation, multi-
detector row CT and ventilation-perfusion scintigraphy were repeated
after 12-24 hours to reevaluate perfusion status.RESULTS 49(87.5%) patients exhibited signiﬁcant reperfu-
sion.7(12.5%) patients exhibited no signiﬁcant reperfusion, 4(7.1%)
patients died during their hospital stay. Plasma lactate, NT-proBNP
and mean pulmonary arterial pressure decreased signiﬁcantly in
all of patients of reperfusion group (7.142.71 mmol/L to 2.040.56
mmol/L; 8672.4201.7 pg/ml to 1559.8  23.5 pg/ml; 52.8217.34
mmHg to 38.1312.32 mmHg, P<0. 01). Plasma lactate and NT-
proBNP levels decreased has a positive correlation with pulmonary
arterial pressure, RV/LV ratio (r 0.68, 0.62, 0.57, P<0.01). No sig-
niﬁcant variation was observed in cTnT levels. As compared
with pre-treatment, there was no signiﬁcant improvement in
levels of plasma lactate and NT-proBNP in negative angiographic
reperfusion patients. 7 cases (7/56,12.5%) in these patients with
bleeding, 2 cases nasal bleeding，1 case bleeding gums, 1 case
hemorrhoids bleeding, 1 case hemoptysis and macroscopic hema-
turia in 2 cases. No death of fatal bleeding reason in the process of
hospital stay.
CONCLUSIONS Thrombolytic therapy with reteplase is effective and
safe for acute pulmonary embolism. Serial measurements of plasma
lactate and NT-proBNP could be useful as a tracking tool to assess the
success or failure of the thrombolytic treatment.KIDNEY DISEASE
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The risk of preexisted microalbuminuria for contrast-induced acute kidney
injury after scheduled coronary angiography among patients with a
preserved renal function
Haoyu Meng, Yingming Zhao, Min Zhang, Xin Lu, Chunjian Li,
Liansheng Wang, Zhijian Yang
First Afﬁliated Hospital of Naning Medical University, Jiangsu Province
Hospital
OBJECTIVES To investigate the association between preexisted
microalbuminuria and contrast-induced acute kidney injury (AKI)
after coronary angiography among patients with a preserved renal
function.
METHODS 612 consecutive patients with a preserved renal function
undergoing scheduled coronary angiography were stratiﬁed into
microalbuminuria group (107 patients) and normal-albuminuria group
(505 patients) according to the albumin to creatinine ratio (ACR)
levels. Microalbuminuria was deﬁned as ACR in the range of 30-300
mg/g and normal-albuminuria was deﬁned as ACR <30 mg/g.
Contrast-induced AKI was deﬁned as a relative increase in serum
creatinine (SCr) concentration of at least 25% or an absolute increase
in SCr of 0.5 mg/dl within 72 hours after the procedure.
RESULTS The peak increases of SCr in microalbuminuria group were
signiﬁcantly larger than those in normal-albuminuria group (10.6 
12.4mmol/L vs 4.8  8.9mmol/L, P¼0.000), and the incidence of AKI
was signiﬁcantly higher in patients with microalbuminuria than those
with normal-albuminuria (12.1% vs 5.0%, P¼0.005). Multivariable
analysis revealed that there was a strong association between micro-
albuminuria and contrast-induced AKI risk after adjusting for con-
founders (P¼0.005).
CONCLUSIONS Preexisting microalbuminuria is associated with
greater risk for AKI in patients with a preserved renal function who
undergo scheduled coronary angiography.GW26-e5379
Short-term Peri-procedural Common Doses (Double-Dose vs Usual-dose)
of Atorvastatin for Prevention of Contrast-Induced Acute Kidney Injury and
Long-term Outcomes in Patients with Different High CRP Levels
undergoing Coronary Angiography or Percutaneous Coronary Intervention
Yong Liu,1 Wei Guo,1 Nianjin Xie,1 Yuanhui Liu,1 Hualong Li,1
Dengxuan Wu,1 Yingling Zhou,1 Chongyang Duan,2 Shiqun Chen,2
PingYan Chen,2 Ning Tan,1 Guang Li,1 Jiyan Chen1
1Department of Cardiology, Guangdong Cardiovascular Institute,
Guangdong General Hospital, Guangdong Academy of Medical
Sciences; 2National Clinical Research Center for Kidney Disease,
Department of Biostatistics, Southern Medical University
OBJECTIVES To investigate the effects of short-term peri-procedural
double-dose (vs usual-dose) atorvastatin (both the most common
C242 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5usages) on prevention of contrast-induced acute kidney injury (CI-
AKI) and long-term clinical outcome after coronary angiography (CAG)
or percutaneous coronary intervention (PCI).
METHODS Overall, 1319 patients were enrolled in the ﬁnal analysis
who were administered with peri-procedural double-dose (40 mg/d,
n¼334) or usual-dose atorvastatin (20 mg/d, n¼985) (1w3 days before
and 2w3 days after procedure), who were stratiﬁed into baseline CRP
tertiles. The primary endpoint was CI-AKI (50% or 0.3 mg/dl in-
crease of serum creatinine in 48 hours).
RESULTS 76 (5.8%) patients developed CI-AKI (double vs usual-
dose: 7.9% vs 5.1%, P¼0.061). Multivariable logistic regression
analysis showed that double dose may be associated with increased
risk of CI-AKI (adjusted odds ratio, OR: 2.43, 95%CI: 1.00w5.94,
P¼0.050), especially in patients with high CRP tertiles (OR: 4.95,
95%CI: 1.16w21.04, P¼0.030). Notably, highest (vs lowest) CRP ter-
tiles was an independent risk factor of CI-AKI (adjusted OR: 3.67,
95%CI: 1.09w12.39, p¼0.036), so did females, contrast volume,
emergency PCI and IABP. Median follow-up was 2.43 years, double-
dose atorvastatin did not reveal a beneﬁcial in mortality in Kaplan-
Meier curves analysis (P¼0.271) or multivariate Cox regression
analysis (adjusted hazard ratio: 0.47, 95% CI: 0.10 to 2.18; P¼0.339),
so did them in the highest CRP tertiles (P¼0.866, P¼0.424,
respectively).
CONCLUSIONS Our observational data suggested that double-dose
(vs usual-dose) atorvastatin may be associated with increased risk of
CI-AKI without beneﬁt in long-term clinical prognosis, even in pa-
tients with high CRP level.
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Relationship of Vascular Growth Factors to Arterial Stiffness in Chronic
Kidney Disease Patients
Ruimin Dong,1 Zhenda Zheng,1 Xujing Xie,1 Jieming Zhu,1 Lin Chen,1
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OBJECTIVES Chronic kidney disease (CKD) is characteristically
accompanied by changes in arterial stiffness, and related to increased
occurrence of cardiovascular disease. The links between arterial
stiffness and circulating vascular growth factors are not well
described.
METHODS Patients with CKD stages 2-5 who were not on dialysis
(n¼156, male/female¼91/65; age¼61.410.9 years) were included.
Brachial-ankle pulse wave velocity (baPWV) was used as a measure of
arterial stiffness. Blood samples to measure hepatocyte growth factor
(HGF), vascular endothelial growth factor (VEGF), insulin-like growth
factor 1 (IGF-1) were obtained.
RESULTS Serum levels of HGF and VEGF were correlated with esti-
mated glomerular ﬁltration rate (eGFR) in patients with chronic renal
diseases. Compared with patients with early CKD (stages 2-3), patients
with late CKD (stages 4-5) had elevated serum levels of HGF (P ¼
0.026) and VEGF (P ¼ 0.034), while IGF-1 was slightly increased in
patients with late CKD (P ¼ 0.057). In univariate analysis, PWV posi-
tively correlated with HGF (r ¼ 0.27, P ¼ 0.016), VEGF (r ¼ 0.30, P ¼
0.035), and negatively with eGFR (r ¼ -0.29, P ¼ 0.028). In a multi-
variate analysis only HGF was independent determinant of higher
PWV.
CONCLUSIONS Circulating levels of HGF may be a new marker of
cardiovascular damage in patients with CKD.
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High central venous pressure is associated with acute kidney injury and
mortality in patients underwent cardiopulmonary bypass surgery
Yanli Yang, Enming Qing, Jun Ma
Beijin Anzhen Hospital, Capital Medical University
OBJECTIVES The pathophysiology of AKI after cardiovascular sur-
gery is multifactorial. The relative importance of high central
venous pressure (CVP) has not been addressed previously.We
sought to investigate the relationship between high CVP, AKI, and
mortality in patients undergoing cardiac surgery with cardiopul-
monary bypass.METHODS All patients aged 18 years or older who underwent cardiac
surgery with CPB between July 1, 2013, and May 31, 2014, were pro-
spectively reviewed. Patients were excluded when renal artery were
involved before and during surgery. Patients were dichotomized into
1) High CVP group: CVP value was higher than 10 mmHg, and 2) Low
CVP group: CVP value was lower than 10 mmHg. CVP measurement
was referred to the fourth intercostal level at the end of surgery. All
patients were followed by telephone. The primary outcome was AKI
and mortality. AKI was deﬁned according to the Kidney Disease
Improving Global Outcomes (KDIGO) criteria.
RESULTS A total of 1941 patients were included in this prospectively
observed study between July 1, 2013, and May 31, 2014 in AnZhen
Hospital. Mean age was 51.9513.65 years, and 46.26% patients were
male. Valve surgery (1232, 63.47%) was the major surgery type. 30-day
mortality was 1.86% overall. Of all patients, 433(22.31%) developed
AKI. In high CVP group, the KDIGO stage1 (34.33 %), stage 2 (5.74%),
and stage3 (0.31%) were respectively higher than that in low CVP
group with stage 1 (5.53 %), stage 2 (0.96%), and stage 3 (1.05%). In a
median follow-up time of 9.2 months, 89(4.59%) patients died. In
multivariate analysis, CVP remained the independent predictor of
survival (hazard ratio:1.2 per mmHg increase, 95% conﬁdence inter-
val: 1.11-1.29, P <0.0001).
CONCLUSIONS High level of CVP is associated with the develop-
ment of AKI, which suggests a role of venous congestion in devel-
oping. High CVP was independently related to all-cause mortality in
patients undergoing cardiovascular surgery with cardiopulmonary
bypass. Further studies will need to assess whether or not CVP at the
end of surgery could be used to guide intervention and improve
outcomes.
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Assessment of Left Ventricular Dissipative Energy Loss by Vector Flow
Mapping in End Stage Renal Disease Patients
Yue Zhong, Li Rao
Department of cardiology, West China Hospital of Sichuan University,
Chengdu, China
OBJECTIVES To assess left ventricular dissipative energy loss (EL) by
vector ﬂow mapping in subjects with end-stage renal disease (ESRD),
and to evaluate the connection between blood ﬂow efﬁciency and
asymptomatic changes in cardiac function.
METHODS ESRD patients with preserved left ventricular ejection
fraction that consisted of group on peritoneal dialysis (PD group),
group on hemodialysis (HD group) and group on preparation for
dialysis session (PRE group) were examined by echocardiography as
well as normal subjects. Vector ﬂow mapping analysis was then per-
formed from the apical 4-chamber view to calculate the EL value
during diastole and systole in the left ventricle (LV).
RESULTS Conventional transthoracic echocardiography and left
ventricular EL calculation were successfully performed in 63 cases
and 50 controls. Mean diastolic EL were 90.1861.11 versus
25.1411.57 mW/m (P <0.001) and mean systolic EL 26.8510.66
versus 13.305.26mW/m (P <0.001) in cases and controls, respec-
tively. Signiﬁcant difference between PD group and PRE group in
diastolic EL was found (66.9840.59 versus 114.2270.52 mW/m,
P ¼0.035). The diastolic EL had a signiﬁcant correlation with E/e’ ratio
(r ¼0.746, P <0.001), and the systolic EL was positively related with
the diastolic EL (r ¼0.617, P <0.001).
CONCLUSIONS Impaired blood ﬂow efﬁciency was detected in ESRD
patients using dissipative EL derived from vector ﬂow mapping. The
EL value could be used to evaluate therapeutic effects of dialysis upon
cardiac function in ESRD patients.
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Serum cystatin C is associated with reverse-dipper pattern of blood
pressure in hypertensive patients
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OBJECTIVES The relationships between deterioration and prognosis
of chronic kidney disease and circadian variations of blood pressure
